During the past decade, Nuclear medicine department CHRU de NANCY conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Nuclear medicine department CHRU de NANCY" are "Cognitive Disorder" (1 trials), "DaTSCAN SPECT Scans" (1 trials) and "Neurodegenerative Diseases" (1 trials). Many other conditions were trialed in "Nuclear medicine department CHRU de NANCY" in a lesser frequency.

Most popular intervention types in "Nuclear medicine department CHRU de NANCY" are "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "18F-FDG PET-CT (fluorodesoxyglucose positron emission tomography)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nuclear medicine department CHRU de NANCY" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Nuclear medicine department CHRU de NANCY". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Nuclear medicine department CHRU de NANCY, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nuclear medicine department CHRU de NANCY, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".